European Journal of Pharmaceutics and Biopharmaceutics 2007-06-01

Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled clonidine zero-order release.

Xiaoping Zhan, Sijing Chen, Guochun Tang, Zhenmin Mao

Index: Eur. J. Pharm. Biopharm. 66(3) , 429-34, (2007)

Full Text: HTML

Abstract

Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane was synthesized by UV curing method in our laboratory for the first time. When above-mentioned monomers were in the weight ratio of 4:4:2, the membrane not only had perfect permeation property but also had excellent plasticity, so the membrane made from monomers in the ratio of 4:4:2 was chosen as an optimized membrane. The optimized membrane provided perfect linear permeation properties in clonidine transdermal drug delivery system. The permeation rate decreased in proportion to the thickness of membrane. When the concentrations of clonidine were in the range of 0.5-7.0mg/ml, the permeation rate was proportional to the square root of clonidine concentrations. The optimized membrane was characterized by FTIR, DSC and SEM.


Related Compounds

  • n-Butyl fumarate
  • 4-Hydroxybutyl acr...

Related Articles:

Designing greener plasticizers: Effects of alkyl chain length and branching on the biodegradation of maleate based plasticizers.

2015-09-01

[Chemosphere 134 , 106-12, (2015)]

Composition-explicit distillation curves of diesel fuel with glycol ether and glycol ester oxygenates: fuel analysis metrology to enable decreased particulate emissions.

2008-10-15

[Environ. Sci. Technol. 42(20) , 7682-9, (2008)]

Biodegradation of potential diesel oxygenate additives: dibutyl maleate (DBM), and tripropylene glycol methyl ether (TGME).

2003-08-01

[Chemosphere 52(5) , 861-8, (2003)]

Contact dermatitis from dibutyl maleate.

1985-11-01

[Contact Dermatitis 13(5) , 337-8, (1985)]

Occupational dermatitis from dibutyl maleinate.

1985-11-01

[Contact Dermatitis 13(5) , 314-6, (1985)]

More Articles...